DNA analysis of ancient mummy, thought to have smallpox, points to Hepatitis B instead

January 04, 2018

HAMILTON, ON, Jan. 4, 2018 - A team of scientists has sequenced the complete genome of an ancient strain of the Hepatitis B virus (HBV), shedding new light on a pervasive, complex and deadly pathogen that today kills nearly one million people every year.

While little is known about its evolutionary history and origin, the findings confirm the idea that HBV has existed in humans for centuries.

The findings are based on genomic data extracted from the mummified remains of a small child buried in the Basilica of Saint Domenico Maggiore in Naples, Italy.

Previous scientific analysis of the 16th century remains--which did not include DNA testing--suggested the child was infected with Variola virus, or smallpox. In fact, this was the oldest evidence for the presence of smallpox in Medieval remains and a critical time stamp for its origins.

Using advanced sequencing techniques, researchers now suggest otherwise--the child was actually infected by HBV. Interestingly, children infected with HBV infections can develop a facial rash, known as Gianotti-Crosti syndrome. This may have been misidentified as smallpox and illustrates the trickiness of identifying infectious disease in the past.

The findings are published online in the journal PLOS Pathogens.

"These data emphasize the importance of molecular approaches to help identify the presence of key pathogens in the past, enabling us to better constrain the time they may have infected humans," explains Hendrik Poinar, an evolutionary geneticist with the McMaster Ancient DNA Centre and a principal investigator with the Michael G. DeGroote Institute for Infectious Disease Research.

Using small tissue samples of skin and bone, scientists were able to tease out tiny fragments of DNA and then stitch together pieces of genetic information to create a much more complete picture.

While viruses often evolve very rapidly -- sometimes in just days -- researchers suggest that this ancient strain of HBV has changed little over the last 450 years and that the evolution of this virus is complex.

While the team found a close relationship between the ancient and modern strains of HBV, both are missing what is known as temporal structure. In other words, there is no measurable rate of evolution throughout the 450-year period which separates the mummy sample from modern samples.

By some estimates, more than 350 million people living today have chronic HBV infections while approximately one-third of the global population has been infected at some point in their lives. Researchers suggest that the underline the importance of studying ancient viruses.

"The more we understand about the behaviour of past pandemics and outbreaks, the greater our understanding of how modern pathogens might work and spread, and this information will ultimately help in their control," says Poinar.
-end-
Attention editors: High-resolution photos of the mummy and Hendrik Poinar can be found at this link: https://adobe.ly/2jy0Dkg

Credit information: Mummy photo: Gino Fornaciari, University of Pisa

Hendrik Poinar photo: JD Howell, McMaster University

McMaster provides a high definition broadcast studio that can connect with any television broadcaster around the world. To book an interview please contact:

Wade Hemsworth
Manager, Media Relations
McMaster University
905-525-9140, ext. 27988
289-925-8382 (c)
hemswor@mcmaster.ca

Michelle Donovan
Manager, Media Relations
McMaster University
905-525-9140, ext. 22869
905-512-8548 (c)
donovam@mcmaster.ca

McMaster University

Related Hepatitis Articles from Brightsurf:

Busting Up the Infection Cycle of Hepatitis B
Researchers at the University of Delaware have gained new understanding of the virus that causes hepatitis B and the ''spiky ball'' that encloses its genetic blueprint.

Liver cancer: Awareness of hepatitis D must be raised
Scientists from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have studied the most serious consequence of chronic hepatitis: hepatocellular carcinoma.

Hepatitis B: New therapeutic approach may help to cure chronic hepatitis B infection
Researchers at Helmholtz Zentrum München, Technical University of Munich (TUM) and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B.

Anti-hepatitis medicine surprises
A new effective treatment of hepatitis C not only combats the virus, but is also effective against potentially fatal complications such as reduced liver functioning and cirrhosis.

Nanotechnology delivers hepatitis B vaccine
X-ray imaging shows that nanostructured silica acts as a protective vehicle to deliver intact antigen to the intestine so that it can trigger an immune response.

Checkmate for hepatitis B viruses in the liver
Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model.

How common is Hepatitis C infection in each US state?
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.

New strains of hepatitis C found in Africa
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa.

High stability of the hepatitis B virus
At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months.

Findings could lead to treatment of hepatitis B
Researchers have gained new insights into the virus that causes hepatitis B -- a life-threatening and incurable infection that afflicts more than 250 million people worldwide.

Read More: Hepatitis News and Hepatitis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.